Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Neuroendocrinology|August 23, 2008
Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in FranceC Lombard-Bohas, E Mitry, D O'Toole, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerA de Gramont, A Figer, M Seymour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerA de Gramont, A Figer, M Seymour, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort studyF Pagès, T André, J Taieb, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2012
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinomaJ B Bachet, R Maréchal, P Demetter, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 13, 2018
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trialY Touchefeu, R Guimbaud, C Louvet, et al.ESMO Open|May 7, 2025
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiativeJ Taieb, J Seligmann, D Modest, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2011
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panelJ-L Van Laethem, C Verslype, J L Iovanna, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trialM Hebbar, B Chibaudel, T André, et al.Pageof 13